CASI Pharmaceuticals (CASIF) Inventory Average (2024 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Inventory Average came in at $2.1 million in Q4 2025, down 29.94% on a QoQ basis from $3.0 million in Q3 2025.
CASI Pharmaceuticals (CASIF) Inventory Average (2024 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 2 years of Inventory Average data on file, last reported at $2.1 million in Q4 2025.
- Quarterly Inventory Average changed N/A year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, down 99.96% from the prior year.
- Inventory Average retreated to $2.1 million in Q4 2025, from $3.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $7.9 billion in Q1 2024 to a low of $2.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | 1.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Jun 30, 2024 | 7.31 Bn |
| Mar 31, 2024 | 7.95 Bn |